Clinical Trial Update: Use of Sitagliptin to Decrease Microalbuminuria [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating sitagliptin for reducing microalbuminuria in patients with type 2 diabetes; the study was terminated and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microalbuminuria
• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Type 2 Diabetes, Microalbuminuria | Phase 4 | Status: TERMINATED | Results posted: 2017-08-10